John Wills
John W. Wills obtained his PhD in medicine from Swansea University, UK in November 2014. His doctoral thesis focussed on the development and optimisation of methods to understand the cellular delivery, DNA-damaging capacity and physiologic behavior of engineered nanomaterials. John joined the Mechanistic Studies Division (HECSB, ERHSD, EHSRB) at Health Canada as an NSERC visiting fellow in December 2014. His current work involves the development of novel benchmark dose algorithms for quantitative interpretation of genetic toxicity dose response data, as well as the development and validation of physiologically representative 3-D in vitro models for chemical and nanomaterial safety evaluation.